Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1999 2
2001 2
2002 3
2003 4
2004 1
2005 2
2006 6
2007 3
2008 3
2009 9
2010 9
2011 19
2012 27
2013 32
2014 29
2015 34
2016 24
2017 17
2018 18
2019 17
2020 17
2021 18
2022 20
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23749925

285 results

Results by year

Filters applied: . Clear all
Page 1
Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K, Minamimoto R, Yao M, Makiyama K, Murakami T, Sano F, Hayashi N, Tateishi U, Ishigaki H, Kishida T, Miura T, Kobayashi K, Noguchi S, Inoue T, Kubota Y, Nakaigawa N. Namura K, et al. BMC Cancer. 2010 Dec 3;10:667. doi: 10.1186/1471-2407-10-667. BMC Cancer. 2010. PMID: 21129184 Free PMC article.
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H, Kondo K, Kawahara T, Kaneta T, Tateishi U, Ueno D, Namura K, Kobayashi K, Miyoshi Y, Yumura Y, Makiyama K, Hayashi N, Hasumi H, Osaka K, Yokomizo Y, Teranishi JI, Hattori Y, Inoue T, Uemura H, Yao M, Nakaigawa N. Ito H, et al. Cancer Chemother Pharmacol. 2017 May;79(5):855-861. doi: 10.1007/s00280-017-3275-z. Epub 2017 Mar 22. Cancer Chemother Pharmacol. 2017. PMID: 28331985
Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Fuccio C, Ceci F, Castellucci P, Spinapolice EG, Palumbo R, D'Ambrosio D, Bernardo A, Brunocilla E, Schiavina R, Maffione AM, Chondrogiannis S, Grassetto G, Colletti PM, Rubello D, Fanti S, Trifirò G. Fuccio C, et al. Clin Nucl Med. 2014 Jun;39(6):e320-4. doi: 10.1097/RLU.0000000000000382. Clin Nucl Med. 2014. PMID: 24566409
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Nakaigawa N, Kondo K, Kaneta T, Tateishi U, Minamimoto R, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Hayashi N, Osaka K, Muraoka K, Izumi K, Kawahara T, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Inoue T, Yao M. Nakaigawa N, et al. Cancer Chemother Pharmacol. 2018 Apr;81(4):739-744. doi: 10.1007/s00280-018-3542-7. Epub 2018 Feb 20. Cancer Chemother Pharmacol. 2018. PMID: 29464355
285 results